[HTML][HTML] Immunohistochemical characterization of subtypes of male breast carcinoma
Y Ge, N Sneige, MA Eltorky, Z Wang, E Lin… - Breast Cancer …, 2009 - Springer
Introduction Male breast cancer accounts for around 1% of all breast cancer cases but the
incidence has risen in recent years. This study aimed to classify the molecular subtypes of …
incidence has risen in recent years. This study aimed to classify the molecular subtypes of …
Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact
C Nilsson, I Johansson, C Ahlin, S Thorstenson… - Acta …, 2013 - Taylor & Francis
Background. Male breast cancer (MBC) is an uncommon disease and there is limited
information on the prognostic impact of routinely used clinicopathological parameters …
information on the prognostic impact of routinely used clinicopathological parameters …
The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study
XF Yu, WL Feng, LL Miao, B Chen, HJ Yang - The Breast, 2013 - Elsevier
Background Male breast cancer (MBC) is rare. Molecular subtype has been utilized widely
in female breast cancer. But the relationship between subtype and prognosis in MBC …
in female breast cancer. But the relationship between subtype and prognosis in MBC …
[HTML][HTML] Molecular subtyping of male breast cancer by immunohistochemistry
R Kornegoor, AHJ Verschuur-Maes, H Buerger… - Modern Pathology, 2012 - Elsevier
Molecular subtyping of breast cancer by gene expression has proven its significance in
females. Immunohistochemical surrogates have been used for this classification, because …
females. Immunohistochemical surrogates have been used for this classification, because …
Clinicopathological and immunohistochemical characteristics in male breast cancer: a retrospective case series
G Masci, M Caruso, F Caruso, P Salvini… - The …, 2015 - academic.oup.com
Background. Due to its rarity, male breast cancer (mBC) remains an inadequately
characterized disease, and current evidence for treatment derives from female breast cancer …
characterized disease, and current evidence for treatment derives from female breast cancer …
[HTML][HTML] Characterisation of male breast cancer: a descriptive biomarker study from a large patient series
MP Humphries, S Sundara Rajan, H Honarpisheh… - Scientific reports, 2017 - nature.com
Male breast cancer (MBC) is rare. We assembled 446 MBCs on tissue microarrays and
assessed clinicopathological information, together with data from 15 published studies …
assessed clinicopathological information, together with data from 15 published studies …
Male versus female breast cancers: a population-based comparative immunohistochemical analysis
D Muir, R Kanthan, SC Kanthan - Archives of pathology & …, 2003 - meridian.allenpress.com
Context.—The rate of male breast cancer is a small fraction of that observed in females, thus
severely limiting our understanding of the pathogenesis of this condition. It remains unclear …
severely limiting our understanding of the pathogenesis of this condition. It remains unclear …
Male breast cancer: Looking for better prognostic subgroups
Abstract Purpose Male Breast Cancer (MBC) remains a poor understood disease.
Prognostic factors are not well established and specific prognostic subgroups are warranted …
Prognostic factors are not well established and specific prognostic subgroups are warranted …
Prognostic significance of tumor subtypes in male breast cancer: a population-based study
JP Leone, J Leone, AO Zwenger, J Iturbe… - Breast cancer research …, 2015 - Springer
Substantial controversy exists about the prognostic role of tumor subtypes in male breast
cancer (MaBC). The aim of this study was to analyze the characteristics of each tumor …
cancer (MaBC). The aim of this study was to analyze the characteristics of each tumor …
[HTML][HTML] Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes
A Sánchez-Muñoz, L Vicioso, A Santonja, M Álvarez… - Modern …, 2018 - nature.com
Male breast cancer is a rare disease that is still poorly understood. It is mainly classified by
immunohistochemistry as a luminal disease. In this study, we assess for the first time the …
immunohistochemistry as a luminal disease. In this study, we assess for the first time the …